Recent advances in triple negative breast cancer: the immunotherapy era

Several accomplishments have been achieved in triple-negative breast cancer (TNBC) research over the last year. The phase III IMpassion130 trial comparing chemotherapy plus atezolizumab versus chemotherapy plu...

Source: BMC Medicine - May 9, 2019 Category: Internal Medicine Authors: Antonio Marra, Giulia Viale and Giuseppe Curigliano Tags: Minireview Source Type: research